Denali Therapeutics Inc. ($DNLI)
Filing Information
| Accession Number | 0001666236-26-000015 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 5, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
25,634
Total Value
$0.00
P&L
+inf% (+$500,375.68)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 3, 2026 | Grant/Award | 6,408 | $0.00 | $0.00 | 38,202 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jun 3, 2026 | Grant/Award | 19,226 | $0.00 | $0.00 | 19,226 | Direct | โ | View Details |